New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
05:37 EDTTHOR, HTWRThoratec downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Thoratec to Neutral citing the weaker LVAD market and limited visibility following the company's Q2 results. The firm lowered its price target for shares to $28 from $38. Goldman keeps a Sell rating on peer HeartWare (HTWR) and lowered its price target on the name to $73 from $75.
News For THOR;HTWR From The Last 14 Days
Check below for free stories on THOR;HTWR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
11:41 EDTHTWR, THORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
September 15, 2014
07:21 EDTHTWR, THORHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 9, 2014
16:46 EDTTHORThoratec announces start of Heartmate III U.S. clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use